Dr. Christy discusses the latest research on Fluvoxamine for the treatment of COVID-19: To enlist in a trial go to: stopcovidtrial.wustl.edu REFERENCES: France Observational Study with SSRI/SNRI Sigma 1 Receptor Agonist activity of SSRIs CETF summary on Fluvoxamine: Washington Post…
